Login
$PTHS
$7.15 +$0.00 (0.0%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Scott Plesha Also a director
Chief Executive Officer and President
62 Since 2025
1 year
Not stated $4,153,168
John M. Gay
Chief Financial Officer, Secretary and Treasurer
50 Since 2026
this year
Not stated Not reported
Sai Rangarao
Chief Commercial Officer
42 Since 2025
1 year
2024 $1,723,407

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
5 of 7
stated in the proxy; 1 not stated
Average tenure
2.0 years
from year joined
CEO also chairs the board
No
Peter Greenleaf
Director Age On board Independent Committees Other public boards 2025 pay Source
Peter Greenleaf
56 2025
1 year
Independent
Nominating and Corporate Governance · Chair
None stated $1,133,179
Scott Plesha
62 2025
1 year
Not stated None stated None stated Paid as CEO
Richard Baxter
63 2025
1 year
Not independent None stated None stated $856,764
Todd Davis
65 2023
3 years
Not independent None stated Palvella Therapeutics Inc. $896,764
Andrew Einhorn
66 2025
1 year
Independent
Audit · Chair
None stated $324,738
Ezra Friedberg
56 2021
5 years
Independent
Audit
None stated $896,764
Richard Malamut
67 2023
3 years
Independent
Compensation
None stated Not stated
Matthew Pauls
56 2025
1 year
Independent
Compensation · Chair
Savara Inc. $1,128,179

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Alexandra Wood (Canada) Inc.
Amount not stated
2024

Transfer of Channel common stock and Series C Preferred Stock held by Chromocell Holdings to AWI in satisfaction of a default judgment.

With Channel Open in proxy
certain affiliates of the Representative
$91,512
2024

Rescission of 111,129 shares of Common Stock held by affiliates of the Representative, with refund of consideration.

With the Company Open in proxy
Ligand
Amount not stated
2025

Assignment to Ligand of LNHC's material assets and liabilities relating to the NITRICIL platform technology and ZELSUVMI.

With LNHC Open in proxy
Ligand
Amount not stated
2025

Exclusive license and sublicense of ZELSUVMI rights, with 13% royalty and milestone payments to Ligand.

With LNHC Open in proxy
Ligand
Amount not stated

Master Services Agreement under which LNHC provides development and manufacturing services to Ligand Parties.

With LNHC Open in proxy
Ligand
$18.0 million
2025

Revolving bridge promissory note under which Ligand loaned cash and settled LNHC expenses; maximum borrowing stated.

With LNHC Open in proxy
Ligand
related person based on share ownership in excess of 5%
Amount not stated
2025

Purchase of Series A Preferred Stock in the PIPE Financing.

With the Company Open in proxy
Nomis RoyaltyVest LLC
Amount not stated
2025

Sale to NRV of the Company's rights to a portion of ZELSUVMI revenue payments, with royalty terms.

With the Company Open in proxy
Madison Royalty LLC
on behalf of certain of the Company's management team
Amount not stated
2025

Purchase of a portion of Channel Covered Products revenue rights and related royalty and sublicensing rights.

With the Company Open in proxy
Ligand
related person based on share ownership in excess of 5%
$9,000,000
2025

Purchase of a Convertible Note in the Convertible Note Financing.

With the Company Open in proxy
Balmoral
related person based on share ownership in excess of 5%
$250,000
2025

Purchase of a Convertible Note in the Convertible Note Financing.

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support